169248 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Animal cells White blood cells
Anti-B7-H4 antibodies and immunoconjugates
#902Application of N-terminomics to NETosis in inflammation
#903Antigen-specific helper T-cell receptor genes
#904System and method for capturing and analyzing cells
#905Methods of producing enriched populations of tumor reactive T cells from peripheral blood
#906Systems and methods for sample use maximization
#907Biodosimetry panels and methods
#908Method for identifying altered leukocyte profiles
#909METHOD OF THERAPY
#910Multiparametric method for assessing immune system status
#911BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATION
#912T cell balance gene expression, compositions of matters and methods of use thereof
#913Methods and materials for reducing suppression of immune function
#914Oligonucleotide-mediated quantitative multiplexed immunoassays
#915ELISPOT method having two filter systems
#916Novel MHC molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of MHC molecules
#917COMPOSITIONS AND METHODS FOR DETECTION AND MODULATION OF T CELL MEDIATED IMMUNE RESPONSES AGAINST VIRAL VECTORS UTILIZED FOR GENE THERAPY
#918Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#919Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#920T cell receptors with MHC independent binding to GM-CSF receptor alpha chain
#921Systems and methods for determining a chemical state
#922Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#923Prostate cancer vaccine
#924Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#925Method of reversibly staining a target cell
#926NON-B-LINEAGE CELLS CAPABLE OF PRODUCING ANTIBODY
#927Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
#928ASSAY METHOD
#929Methods for determining the risk of acute graft versus host disease
#930NON-B-LINEAGE CELLS CAPABLE OF PRODUCING ANTIBODY
#931Systems and methods for detecting a biological condition
#932KIR3DL2 binding agents
#933Microfluidic devices for the capture of biological sample components
#934CD28 expression during lenalidomide immune modulation
#935Blood analyzer
#936Microfluidic device and leucocyte antigen mediated microfluidic assay
#937DIAGNOSIS AND TREATMENT OF ASPIRIN-EXACERBATED RESPIRATORY DISEASE (AERD)
#938METHOD FOR SEPARATING CELLS-BEAD COMPLEXES
#939SUBSTRATE FOR SAMPLE HANDLING
#940Methods of isolating and purifying CD8 T cells
#941Compositions and methods
#942KIR3DL2 binding agents
#943High Affinity TCR Proteins and Methods
#944ISOLATION OF CELLS AND BIOLOGICAL SUBSTANCES USING BUOYANT MICROBUBBLES
#945SPECIFIC REMOVAL OF ACTIVATED IMMUNE CELLS
#946Isolation and Use of Human Regulatory T Cells
#947CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#948Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#949Image analysis and measurement of biological samples
#950CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#951Systems and methods for sample use maximization
#952BIOMARKERS OF IMMUNE RESPONSE IN MUCOSAL LESIONS AND THEIR USE WITH THERAPEUTIC VACCINATION
#953Modulation of immunity and CEACAM1 activity
#954Immunological reagents and uses therefor
#955PD-1 specific antibodies and uses thereof
#956CEACAM1 mediated protective immunity
#957Methods of monitoring responsiveness to anti-SMAD7 therapy
#958Optical engine for flow cytometer, flow cytometer system and methods of use
#959Quantitative in situ characterization of biological samples
#960Kits, compositions and methods for detecting a biological condition
#961METHODS OF DETECTING CELLS LATENTLY INFECTED WITH HIV
#962Methods for Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom, and Uses Thereof
#963Microfluidic devices, and methods of making and using the same
#964Predictive biomarkers for CTLA-4 blockade therapy and for PD-1 blockade therapy
#965Detecting cells secreting a protein of interest
#966THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#967Human monoclonal antibodies to CTLA-4
#968Method for increasing the proportion of animal cells secreting galectin-9
#969Phosphorothioate oligonucleotide-labeling of white blood cells
#970Identification of antigen or ligand-specific binding proteins
#971CELLULAR MARKERS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE AND FOR ALZHEIMER'S DISEASE PROGRESSION
#972Methods for detecting Th1 cells
#973Kit for monitoring immune status after transplant and method for monitoring immune status using same
#974Microfluidic device for serial fluidic operations
#975Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#976Image analysis and measurement of biological samples
#977Chromatographic isolation of cells and other complex biological materials
#978Method for labeling intracellular and extracellular targets of leukocytes
#979Regulatory T cells and methods of identifying, obtaining and using to treat immuno-based disorders
#980Method and kit for determining-antibody sensitivity and clone cell strain
#981Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
#982Neutralizing GP41 antibodies and their use
#983Neutralizing GP41 antibodies and their use
#984Method of isolating human antibodies
#985Flow cytometry assay methods
#986Populations of hematopoietic progenitors and methods of enriching stem cells therefor
#987Administration of alpha4beta7 hetero-dimer-specific antibody
#988Methods and kits for detecting IgE-expressing B cells
#989CMV glycoproteins and recombinant vectors
#990Method of reversibly staining a target cell
#991PROTOCOL FOR IDENTIFYING AND ISOLATING ANTIGEN-SPECIFIC B CELLS AND PRODUCING ANTIBODIES TO DESIRED ANTIGENS
#992Rapid and Inexpensive Assay for Evaluation of Antibody Efficacy with Custom-Designed Fluorescent Nanoparticles
#993Magnetic separation of cells
#994Image analysis and measurement of biological samples
#995Reagents, systems and methods for analyzing erythrocytes and platelets
#996Reagents, systems and methods for analyzing white blood cells
#997Flow-through cell counting assay
#998Particle Identification System, Cartridge And Associated Methods
#999PLASMONIC SUBSTRATES FOR METAL-ENHANCED FLUORESCENCE BASED SENSING, IMAGING AND ASSAYS
#1000Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#1001ERYTHROPOIETIC ROLE OF RESIDENT MACROPHAGES IN HEMATOPOIETIC ORGANS
#1002SYSTEM AND METHOD FOR INTEGRATION OF MOBILE DEVICE IMAGING WITH MICROCHIP ELISA
#1003Methods and compositions for cytometric detection of rare target cells in a sample
#1004Heat-transfer resistance based analysis of bioparticles
#1005TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#1006System, method, and article for detecting abnormal cells using multi-dimensional analysis
#1007Dual Specific Binding Proteins Having a Receptor Sequence
#1008Artificial antigen presenting cells and uses thereof
#1009Method to detect the onset and to monitor the recurrence of chronic graft versus host disease in transplantation patients
#1010Low-cost point-of-care assay device
#1011Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#1012METHODS FOR INCREASING THE EFFICIENCY OF HYBRIDOMA GENERATION
#1013Diagnosing and treating inflammatory diseases
#1014Systems, compositions and methods for detecting a biological condition
#1015METHOD AND SYSTEM FOR CELL DETECTION AND ANALYSIS
#1016Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency
#1017Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles
#1018Method of assessing infection status
#1019TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness
#1020Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#1021Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
#1022Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
#1023Humanised anti-CD52 antibodies
#1024Anti-human receptor-type protein tyrosine phosphatase sigma antibody
#1025Detecting cells secreting a protein of interest
#1026Photocrosslinkable Peptide-MHC Complexes for Antigen-Specific T Cells and Methods of Using the Same
#1027Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
#1028DIAGNOSTIC AND SCREENING METHODS FOR INFLAMMATION
#1029Prostate cancer vaccine
#1030Human monoclonal antibodies to CTLA-4
#1031Assay method for peptide specific T-cells
#1032Method and insert for density gradient separation
#1033Antibodies directed against ICOS and uses thereof
#1034Method and kit for rapid isolation of human Foxp3+ Treg cells
#1035Method and Arrangement for Quantifying Subgroups from a Mixed Population of Cells
#1036Anti-TIM-3 antibody
#1037Simple and affordable method for immunophenotyping using a microfluidic chip sample preparation with image cytometry
#1038Image analysis and measurement of biological samples
#1039Reagent and reagent kit for analysis of immature leukocyte
#1040In vivo flow cytometry based on cellular autofluorescence
#1041Image analysis and measurement of biological samples
#1042Cancer vaccine composition
#1043Method to assess patterns of molecular expression
#1044Method of Enhancing Hematopoietic Cell Transplantation
#1045Method and kits for determining platelet susceptibility to activation in a patient
#1046CELL CULTURING FORMULATION AND CULTURING AND QUANTIFICATION METHOD OF CD140B+ CELLS THEREOF
#1047Real-time adaptive immune system and method
#1048IDENTIFICATION OF LIGANDS AND THEIR USE
#1049Counting particles using an electrical differential counter
#1050Pan-kinase activation and evaluation of signaling pathways
#1051Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
#1052Method for detection, differentiation and quantification of T cell populations by way of reverse transcription quantitative real time PCR (RT-qPCR) technology
#1053System and method of verification of a prepared sample for a flow cytometer
#1054Method for the diagnosis of and/or monitoring mucormycosis
#1055Method for the diagnosis and/or prognosis of granulocyte-related inflammatory states
#1056Compositions and methods for the treatment of immune related diseases
#1057System and device for analyzing a fluidic sample
#1058DEVICES AND METHODS FOR ANALYSIS OF SAMPLES WITH DEPLETION OF ANALYTE CONTENT
#1059Methods for detecting Th1 cells
#1060Methods for detecting Th1 cells
#1061CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#1062Multiparametric method for assessing immune system status
#1063Bioreactor for isolation of rare cells and methods of use
#1064Microfluidic devices for the capture of biological sample components
#1065Human B1 cells and uses thereof
#1066Detection of human umbilical cord tissue derived cells
#1067Proteins that bind PI16 and uses thereof
#1068Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#1069Microfluidic assay in idealized microvascular network for characterization of leukocyte adhesion cascade
#1070Microfluidic Cell Separation in the Assay of Blood
#1071Detection of Overtraining Syndrome in an Individual
#1072REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS
#1073Assay for measuring cell-mediated immunoresponsiveness
#1074NEW METHODS FOR ISOLATING TR1 CELLS
#1075B-cell antigen presenting cell assay
#1076IMMUNODOMINANT MHC DR52B RESTRICTED NY-ESO-1 EPITOPES, MHC CLASS II MONOMERS AND MULTIMERS, AND USES THEREOF
#1077METHOD FOR DETECTING REGULATORY T CELLS USING EXPRESSION OF FOLATE RECEPTOR 4 AS INDICATOR, METHOD FOR TREATING DISEASES USING THE DETECTION METHOD, PHARMACEUTICAL COMPOSITION FOR IMMUNOSTIMULATION, AND METHOD FOR TREATING DISEASES USING THE COMPOSITION
#1078FACS-based method for obtaining an antibody sequence
#1079Treatment of neuroinflammatory conditions using antibodies directed against MCAM
#1080Biomarker panels for assessing radiation injury and exposure
#1081Methods of diagnosing and treating pulmonary diseases or disorders
#1082SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
#1083Selective cytopheresis devices and related methods thereof
#1084SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#1085Method and system for disease diagnosis via simultaneous detection of antibodies bound to synthetic and cellular substrates
#1086TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#1087CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#1088Tolerogenic synthetic nanocarriers for allergy therapy
#1089METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#1090METHODS FOR DIAGNOSIS OF IMMUNE RESPONSES AGAINST VIRUSES
#1091Compositions and methods for antibody and ligand identification
#1092Selective cytopheresis devices and related methods thereof
#1093METHOD FOR THE QUANTITATIVE AND QUALITATIVE CHARACTERIZATION OF ANTIGEN-SPECIFIC T CELLS RECOGNIZING A SPECIFIC ANTIGEN
#1094TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#1095Tolerogenic synthetic nanocarriers
#1096Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#1097TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#1098TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#1099Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#1100Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#1101Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#1102Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#1103MHC peptide complexes and uses thereof in infectious diseases
#1104Methods and kits to detect and monitor ovarian cancer and preeclampsia
#1105LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS
#1106VLA-4 AS A BIOMARKER FOR PROGNOSIS AND TARGET FOR THERAPY IN DUCHENNE MUSCULAR DYSTROPHY
#1107Selective cytopheresis devices and related methods thereof
#1108QUALITY ASSAYS FOR ANTIGEN PRESENTING CELLS
#1109Methods of modulating TGFβ signaling
#1110FLOW CYTOMETRY METHOD THROUGH THE CONTROL OF FLUORESCENCE INTENSITIES
#1111Brachyury polypeptides and methods for use
#1112COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#1113System and method based on blood components for estimating human physiological parameters
#1114EphA2 T cell epitopes and uses therefor
#1115Anti-TIM-3 antibody
#1116Immunodiversity Assessment Method and Its Use
#1117Methods and compositions for diagnostic assays for measuring cell mediated immune response
#1118Method of therapy
#1119Compositions and methods for assessing cytotoxicity of single cells
#1120Methods of treating cancer with human monoclonal antibodies to CTLA-4
#1121MULTI-FREQUENCY IMPEDANCE METHOD AND APPARATUS FOR DISCRIMINATING AND COUNTING PARTICLES EXPRESSING A SPECIFIC MARKER
#1122Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
#1123Anti-ILT7 antibody
#1124B cell surface reactive antibodies
#1125Blood analyzer and blood analyzing method
#1126Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy
#1127B-lymphocyte targeting agents for use in a method for the treatment of a disease
#1128Immunological method for detecting active JCV infection
#1129Method for the detection of polypeptide specific immune cells
#1130Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FCγRI receptor (CD64)
#1131BIOMARKERS AND USES THEREOF
#1132Human monoclonal antibodies to CTLA-4
#1133B LYMPHOCYTE STIMULATOR ASSAYS
#1134Method for Determining the Cbl-b Expression
#1135Methods of Detecting Diseases or Conditions Using Phagocytic Cells
#1136Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies
#1137Cell-mediated immunoassays
#1138Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#1139Methods for Modulating Macrophage Proliferation Using Polyamine Analogs
#1140Identification of antigen or ligand-specific binding proteins
#1141Prostate cancer vaccine
#1142Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof
#1143MHC Multimers in Cancer Vaccines and Immune Monitoring
#1144Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
#1145Methods of Using Labeled Ligands Having Human CD4 Specificity
#1146Methods For Detecting Th1 Cells
#1147Microfluidic device for full blood count
#1148Immunity Evaluation Method, Apparatus and Program
#1149DIAGNOSING AND MONITORING INFLAMMATORY DISEASES BY MEASURING COMPLEMENT COMPONENTS ON WHITE BLOOD CELLS
#1150Detecting antigen responsive cells in a sample
#1151METHODS FOR THE ENRICHMENT OF VIABLE FOXP3+ CELLS AND USES THEREOF
#1152Cytokines and Cytokine Receptors with Reduced Immunogenicity
#1153RECOMBINANT MHC MOLECULES USEFUL FOR MANIPULATION OF ANTIGEN-SPECIFIC T-CELLS
#1154Artificial antigen presenting cells and uses therefor
#1155MAGNETIC NANOPARTICLE AND METHOD FOR IMAGING T CELLS
#1156Method for in vitro blood testing
#1157Method of diagnosis and kit therefor
#1158Antibody-secreting cell assay
#1159Methods and compositions related to acetylocholine receptor conjugates
#1160MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
#1161Use of Antibody Secreting Cell Elispot To Assess Antibody Responses Following Antigen Exposure
#1162Methods of diagnosing inflammatory bowel disease
#1163EX VIVO THERAPEUTICS SCREENING OF LIVING BONE MARROW CELLS FOR MULTIPLE MYELOMA
#1164Cell assay kit and method
#1165PREPARATION METHOD
#1166B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#1167Selective cytopheresis devices and related methods thereof
#1168P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#1169PD-1 specific antibodies and uses thereof
#1170Lateral flow based methods and assays for rapid and inexpensive diagnostic tests
#1171NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#1172Cyanine compounds, compositions including these compounds and their use in cell analysis
#1173MARKER FOR DETECTING IL-17-PRODUCING HELPER T CELL, AND METHOD FOR DETECTING IL-17-PRODUCING HELPER T CELL
#1174B LYMPHOCYTE STIMULATOR ASSAYS
#1175Methods for treating chronic lymphocytic leukemia
#1176Chronic lymphocytic leukemia cell line
#1177Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases
#1178Diagnostic method for Alzheimer's disease
#1179IMMUNOGEN PRIORITIZATION FOR VACCINE DESIGN
#1180Synthetic microfluidic blood-brain barrier
#1181USE OF IMMUNOREGULATORY NK CELL POPULATIONS FOR PREDICTING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
#1182Cellular COPD Diagnosis
#1183Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells
#1184METHOD FOR ANALYSIS/IDENTIFICATION OF ANTIBODY GENE AT ONE-CELL LEVEL
#1185Method and System to Detect, Diagnose, and Monitor the Progression of Alzheimer's Disease
#1186Method for evaluation of function of phagocyte
#1187IMMUNOTHERAPEUTIC METHODS AND MOLECULES
#1188Selection of B Cells with Specificity of Interest: Method of Preparation and Use
#1189Method for the Diagnosis of Leukemia Using Caspase-3
#1190Reversible MHC multimer staining for functional purification of antigen-specific T cells
#1191Method for Screening of Active Tuberculosis
#1192Separation of Leukocytes
#1193Cancer vaccine composition
#1194ANTIBODY HAVING AN IMMUNE-ENHANCEMENT FUNCTION
#1195COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#1196MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells
#1197Diagnosis and treatment of diseased and damaged tissue
#1198METHOD FOR IN-VITRO DETECTING PATHOGENIC T HELPER CELLS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES
#1199In vivo flow cytometry based on cellular autofluorescence
#1200HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN SUSD3 AND LIGANDS FOR THE PROTEIN SUSD3